Fajar Surya Wisesa Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Fajar Surya Wisesa Tbk. trades at Rp5,275 (market cap 16.99T), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Fajar Surya Wisesa Tbk. is far larger — about 39.6× Prodia Diagnostic Line Tbk's market cap. Which is the better fit depends on your goals.
| FASW | PRDL | |
|---|---|---|
Market Cap | 16.99T | 428.75B |
Volume | — | 13.83M |
Lot | — | 138.27K |
Turnover | — | 3.27B |
Average Price | — | 236.62 |
Value | — | 3.27B |
Indicative Equilibrium Price | — | 236 |
Indicative Equilibrium Volume | — | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Fajar Surya Wisesa Tbk (the Company) was established based on Notarial Deed No. 20 dated June 13, 1987 of Lenny Budiman, S.H., notary in Jakarta.
Read more on FASW →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →